Sunday, February 12, 2012
 
 
  Home arrow Birth Control arrow Birth Control Archive arrow OCs Containing Cyproterone Increase Risk of Deep Vein Thrombosis (10/01)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

Birth Control May Increase the Risk of Breast Cancer

Oral contraceptives increase the risk of breast cancer by an average of 44 percent in pre-menopausal women who took - or were taking - oral contraceptives (OCs) prior to their first pregnancy (as compared to women who had not used OCs), according to a comprehensive analysis of international studies conducted between 1980-2002, linking breast cancer and contraceptives. ["Oral Contraceptive Use as a Risk Factor for Pre-menopausal Breast Cancer: A Meta-analysis", published in the journal of the Mayo Clinic, October 2006]

Of the 23 studies examined, 21 showed an increased risk of breast cancer with OC use prior to a first pregnancy in pre-menopausal women.

The study seems to reinforce the 2005 classification of oral contraception as a Type 1 carcinogen (cancer-causing agent) to humans by the International Agency for Cancer Research.
[LifeSiteNews.com, 25Oct06]

 
OCs Containing Cyproterone Increase Risk of Deep Vein Thrombosis (10/01) PDF Print E-mail

ORAL CONTRACEPTIVES CONTAINING CYPROTERONE INCREASE RISK OF DEEP VEIN THROMBOSIS: four times more likely to develop deep vein thrombosis, or venous blood clots, than those taking OCs that contain levonorgestrel.

Deep vein thrombosis can cause potentially fatal pulmonary embolism if blood clots travel through the bloodstream and lodge in the lungs. The retrospective case-control study of 24,401 women ages of 16-39, 1992-1999. Of the 26 cases and 144 controls, 14 cases and 114 controls had taken OCs with levonorgestrel, and 12 cases and 30 controls had taken OCs with cyproterone.

The analysis also showed that duration of exposure did not affect risk of venous thromboembolism after cyproterone exposure (Lancet, 10/27). Cyproterone is found in "so-called third-generation" birth control pills, which contain more progestin than older versions, such as those that contain levonorgestrel [Research letter, 27Oct01, Vasilakis-Scaramozza/Jick, (Boston Univ School of Medicine) Lancet Reuters Health, 10/26; Kaiser Daily Reproductive Health Reports, 10/29]

 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2012 All Rights Reserved